Cytotron
is the trade name of the Rotational Field
Quantum Magnetic Resonance Device RFQMR that is
developed by Centre for Advanced Research and
Development (CARD) division of Scalene
Cybernetics in Bangalore, India. It is a new
device developed for Tissue Regeneration,
Degeneration and Repair for the purposes of
treating several chronic or degenerative
diseases such as Cancer & Arthritis. The
treatment modality is non-invasive, painless and
free from side effects. In the Clinical studies
it has been demonstrated that Cytotron is very
effective in curing certain conditions such as a
damaged knee by regenerating the cartilage
tissue or stopping and reversing the growth of a
tumor in cancer.
What is the Principle of RFQMR in Tissue Regeneration and Degeneration?
The cellular mechanisms and processes involved are complex, RFQMR works on the principle of altering cell membrane potential and "Jamming" the "Command and Control" of the target tissue cells, by altering the proton spin in the inside and outside the cells.
How does RFQMR work in Tissue Regeneration of the cartilage?
Like other tissues, bone and cartilage are constantly being built up and broken down by a variety of metabolic and physical influences. The major stimulus for bone and cartilage formation is a signal generated when these structures are subjected to tension or compression. This explains why bone atrophies in the absence of any significant pressure, such as weightlessness during space travel or immobilization in a cast. The transmission of this signal is also impaired following joint injury due to trauma or diseases such as osteoarthritis. QMR is designed to characterize and reproduce the required signal that initiates these regenerative activities by the induction of a spin in the hydrogen atoms thus creating a streaming potential in the extra cellular matrix (ECM) when bone or cartilage are placed under a load.
In other words, when you take a step, putting weight on the joint, the cartilage is compressed, the fluid gets displaced, and it carries with it mobile ions, the sodium ions, leaving behind the negatively charged proteoglycan carboxyl and sulfate ions. This generates an electric potential because you have "unneutralised" negative charges. This is called a streaming potential. RFQMR can recreate this streaming potential and its restorative rewards in joints impaired due to disease or trauma even though they are at rest.
What are the future applications of RFQMR?
RFQMR is already being used for rehabilitating osteoarthritis and cancer patients and In future RFQMR can prove effective as a non-invasive solution in relieving pain and disability due to trauma, temporo-mandibular joint disease, tinnitus, peridontal disease, carpal tunnel syndrome, osteoporosis, tendonitis, convalescence following surgical repair of ligaments, fresh bone fractures in elderly, aseptic necrosis, fibromyalgia, sciatica, post-polio syndrome, migraine, metatarsalgia, acute burns, immune deficiency disorders, drug resistant epilepsy, diabetic neuropathy, herniated disk, problem wound healing, Stimulation of Angiogenic Growth Factor and promoting Coronary and peripheral pro-angiogenesis and retarding the Angiogenic Growth Factor to promote.
Another possible application of QMR could be Electroporation. Electroporation involves directly applying QMR pulses of millionths of a second duration and field strength of 100-1500 volts per centimeter to living cells. These pulses cause nanoscopic pores to open up through the cell's membrane. When the pulse stops, the pores close again, trapping the drug or DNA inside the cell. Electroporation can be carried out by applying the QMR pulses either directly to the target tissue to be treated in a living organism, or to cell suspensions and isolated organs. This application of QMR may go a long way, as it will open up the potential for new approaches to medical problems where successful treatment depends on finding ways for the therapeutic molecules to reach the cell interior. This includes - among others - treatments such as cancer chemotherapy, the delivery of DNA for gene therapy and DNA vaccines, the delivery of drugs for treating cardiac and vascular problems as well as the treatment of the eye disease. After more studies are completed, many other potential applications such as the treatment of haemophilia and other genetic defects or the treatment of cardiovascular diseases and the prevention of atherosclerosis can be explored.
Inventor
Of Cytotron